Research shows that patients with Peripheral Vascular Disease have lower levels of Specialized Pro-Resolving Mediators, or SPMs, than do healthy people. Patients with low SPMs also have a low Omega-3 index, low availability of the basic precursor to the substrates to produce SPMs, and they have deficiency in switching mechanisms that allow conversion of Omega-3s into SPM production. The deficiency can only be overcome by taking SPMs in another form. Particularly among obese patients or those with metabolic syndrome, taking SPMs can be effective in improving their metabolic pathway insufficiencies.

Share this:

Resources from our research partners and collaborations

Sign up for the MHICN Newsletter

Your Weekly Nutrition Bulletin features the latest content on topics spanning our therapeutic platforms from MHICN research staff and clinical partners. Receive videos, clinical modules, research reviews and more by email each week. Sign up here or view previous weeks' newsletters.

Subscribe View Newsletter Archives

Continuing Education

MHICN has partnered with leaders in preventive medicine, integrative medicine, and medical education to provide cutting-edge education for providers of all backgrounds with an interest in functional and lifestyle medicine. We are excited to share these free educational modules featuring podcasts, videos, and print articles.

Learn More